Cargando…

Twenty years’ observation of subcutaneous pollen allergoid immunotherapy efficacy in adults

INTRODUCTION: It is valuable to determine the long-term efficacy of allergen-specific immunotherapy (SIT) and whether it can cure allergy. AIM: For this study, patients were prospectively observed for 20 years after completion of SIT to determine its effectiveness. MATERIAL AND METHODS: A total of 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bożek, Andrzej, Krupa-Borek, Izabella, Jarzab, Jerzy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2017
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799760/ https://www.ncbi.nlm.nih.gov/pubmed/29422821 http://dx.doi.org/10.5114/ada.2017.72462

Ejemplares similares

Safety and Efficacy of Tree Pollen Specific Immunotherapy on the Ultrarush Administration Schedule Method Using Purethal Trees
por: Bozek, Andrzej, et al.
Publicado: (2014)

Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2‐year double‐blind, placebo‐controlled, randomized trial plus 1‐year open‐label extension
por: Worm, Margitta, et al.
Publicado: (2019)

Specific immunotherapy with mugwort pollen allergoid reduce bradykinin release into the nasal fluid
por: Gawlik, Radoslaw, et al.
Publicado: (2016)

A novel and well tolerated mite allergoid subcutaneous immunotherapy: evidence of clinical and immunologic efficacy
por: Roger, Albert, et al.
Publicado: (2014)

A non-stationary Markov model for economic evaluation of grass pollen allergoid immunotherapy
por: Bilancia, Massimo, et al.
Publicado: (2020)

11 Efficacy and Tolerability of HDM Injective Immunotherapy With Monomeric Allergoid
por: Compalati, Enrico, et al.
Publicado: (2012)

First‐in‐human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy
por: Nieto, Antonio, et al.
Publicado: (2022)

Poster 1000: Efficacy and safety of specific sublingual immunotherapy with carbamylated allergoid tablets of ragweed pollen: a dose-ranging study
por: Compalati, Enrico, et al.
Publicado: (2014)

Characteristics of Atopic Bronchial Asthma in Seniors over 80 Years of Age
por: Bożek, Andrzej, et al.
Publicado: (2013)

T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy
por: Reithofer, Manuel, et al.
Publicado: (2023)

Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis
por: Shershakova, Nadezda, et al.
Publicado: (2015)

Evaluation of subcutaneous immunotherapy with birch pollen extract for pollen-food allergy syndrome
por: Hamada, Masaaki, et al.
Publicado: (2021)

565 Sensitization Profile in Severe Asthma
por: Bozek, Andrzej, et al.
Publicado: (2012)

Association between cancer and allergies
por: Kozłowska, Renata, et al.
Publicado: (2016)

Allergic rhinitis, bronchial asthma and other allergies in patients with Alzheimer’s disease: unnoticed issue
por: Bożek, Andrzej, et al.
Publicado: (2016)

A meta‐analysis on allergen‐specific immunotherapy using MCT(®) (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis
por: Becker, Sven, et al.
Publicado: (2021)

Clinical Efficacy Evaluation of 1-Year Subcutaneous Immunotherapy for Artemisia sieversiana Pollen Allergic Rhinitis by Serum Metabolomics
por: Shi, Hai-Yun, et al.
Publicado: (2020)

Subcutaneous Immunotherapy (SCIT) with the New Polymerized Molecular Allergoid Alt a1: A Pilot Study in Children with Allergic Rhinitis Sensitized to Alternaria Alternata
por: Brindisi, Giulia, et al.
Publicado: (2023)

The relative clinical impact of sublingual immunotherapy with carbamylated monomeric allergoids on allergic respiratory symptoms
por: Compalati, Enrico, et al.
Publicado: (2015)

Intradermal Phleum pratense allergoid immunotherapy. Double‐blind, randomized, placebo‐controlled trial
por: Sola Martínez, Francisco Javier, et al.
Publicado: (2020)

Evaluation of safety and tolerability of a rush up-dosing allergen-specific immunotherapy with grass pollen, birch, hazel, and alder allergoid in children with allergic rhinoconjunctivitis, with or without asthma
por: Traina, Giovanni Maria, et al.
Publicado: (2021)

A novel peanut allergoid is safe and effective in immunotherapy in a peanut allergy mouse model
por: Smit, J, et al.
Publicado: (2013)

Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy
por: Worm, M., et al.
Publicado: (2018)

Transcriptome analysis and safety profile of the early-phase clinical response to an adjuvanted grass allergoid immunotherapy
por: Starchenka, Sviatlana, et al.
Publicado: (2019)

Prevalence of IgE-mediated allergy and evaluation of Th1/Th2 cytokine profiles in patients with severe bronchial asthma
por: Rogala, Barbara, et al.
Publicado: (2015)

Different Development Forms of Local Allergic Rhinitis towards Birch
por: Bozek, Andrzej, et al.
Publicado: (2020)

Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial
por: Bożek, Andrzej, et al.
Publicado: (2017)

A case of lipoatrophic panniculitis in a 2-year-old boy
por: Weryńska-Kalemba, Maria, et al.
Publicado: (2016)

Subcutaneous Immunotherapy in Patients with Fagales Pollen-Induced Oral Allergy Syndrome
por: Kong, Nasil, et al.
Publicado: (2019)

An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial
por: Chaker, A. M., et al.
Publicado: (2016)

Effectiveness and safety of a microcrystalline tyrosine‐adjuvanted Dermatophagoides pteronyssinus allergoid immunotherapy in adult patients with allergic asthma and rhinitis: A real‐life prospective observational study
por: Padró, Clara, et al.
Publicado: (2022)

484 Allergen Standardisation in Allergens and Allergoids—Challenges and Considerations
por: Skinner, Murray, et al.
Publicado: (2012)

Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany
por: Verheggen, Bram G, et al.
Publicado: (2015)

Peripheral effector memory regulatory T cells are incremented and functionally enhanced in successful mite monomeric allergoid sublingual immunotherapy
por: Petrarca, Claudia, et al.
Publicado: (2020)

Establishment and characterization of murine models of asthma and subcutaneous immunotherapy for Humulus pollen allergy
por: Xi, Guang P., et al.
Publicado: (2021)

Examples of adverse effects after biological therapy
por: Hadas, Ewa, et al.
Publicado: (2020)

Real-Life Effectiveness of Subcutaneous Immune Therapy with Carbamylated Monomeric Allergoids on Mite, Grass, and Pellitory Respiratory Allergy: A Retrospective Study
por: Di Gioacchino, Mario, et al.
Publicado: (2022)

98 Specific IGE and IGG Binding to Allergoids of Phleum pratense
por: Cases, Barbara, et al.
Publicado: (2012)

Novel vaccines targeting dendritic cells by coupling allergoids to mannan
por: Benito-Villalvilla, Cristina, et al.
Publicado: (2018)

Can atopy have a protective effect against cancer?
por: Bożek, Andrzej, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2s88rb24b6th1n14j5n6qk0bt9